MARKET RESEARCHES OF DRUG PROVISION IN GLAUCOMA PATIENTS IN THE TYUMEN REGION

There are today 105 million people suffering from glaucoma worldwide, of them 9.1 million are blind in both eyes. In the Russian Federation, the number of glaucoma patients approximates 1 million. Glaucoma is one of the leading places among the causes of loss of visual function. In the past 5 years, the role of glaucoma has increased dramatically as one of the causes of disability therefore the optimization of drug provision in patients with this condition is of particular importance. The paper gives the results of market researches of drug provision in glaucoma patients in the Tyumen Region. Based on the findings, the authors elaborated and tested a methodological approach relied on the principles of the pharmaceutical market research concept and on the specific features of drug consumption by glaucoma patients in the Tyumen Region. Guidelines have been prepared to satisfy information needs and to improve knowledge in medical and pharmaceutical workers and the population.